306 related articles for article (PubMed ID: 1851136)
21. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
Pietra G; Semino C; Cagnoni F; Boni L; Cangemi G; Frumento G; Melioli G
J Med Virol; 2000 Nov; 62(3):354-63. PubMed ID: 11055246
[TBL] [Abstract][Full Text] [Related]
22. Lysis of herpes simplex virus (HSV) infected targets. IV. HSV-induced change in the effector population.
Hendricks RL; Sugar J
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):208-13. PubMed ID: 3972502
[TBL] [Abstract][Full Text] [Related]
23. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes.
Torpey DJ; Lindsley MD; Rinaldo CR
J Immunol; 1989 Feb; 142(4):1325-32. PubMed ID: 2464644
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells.
López-Guerrero JA; Alarcón B; Fresno M
J Gen Virol; 1988 Nov; 69 ( Pt 11)():2859-68. PubMed ID: 2846762
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
Mikloska Z; Cunningham AL
J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
Muñoz A; Carrasco L; Fresno M
J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
[TBL] [Abstract][Full Text] [Related]
27. Natural killer cell-mediated lysis of herpes simplex virus-infected fibroblasts: inability to detect soluble factors that contribute to lysis.
Oh SH; Trinchieri G; Bandyopadhyay S; Starr SE
Cell Immunol; 1990 May; 127(2):221-9. PubMed ID: 2328528
[TBL] [Abstract][Full Text] [Related]
28. Defective NK cell activity following thermal injury.
Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
[TBL] [Abstract][Full Text] [Related]
29. Lysis of human arterial smooth muscle cells infected with herpesviridae by peripheral blood mononuclear cells: implications for atherosclerosis.
Datta SK; Tumilowicz JJ; Trentin JJ
Viral Immunol; 1993; 6(2):153-60. PubMed ID: 8216714
[TBL] [Abstract][Full Text] [Related]
30. [The interrelation of the expression of HLA class I and II proteins and of the costimulatory proteins CD11a/CD18 and CD16 with the lytic activity of resting and activated natural killer lymphocytes].
Musatov MI; Petrova ED; Konenkov VI
Tsitologiia; 1997; 39(7):617-28. PubMed ID: 9490502
[TBL] [Abstract][Full Text] [Related]
31. Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines.
Leibson PJ; Hunter-Laszlo M; Douvas GS; Hayward AR
J Clin Immunol; 1986 May; 6(3):216-24. PubMed ID: 3013922
[TBL] [Abstract][Full Text] [Related]
32. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
33. Lysis by natural killer cells requires viral replication and glycoprotein expression.
Schattner A; Rager-Zisman B
Immunol Lett; 1986 Oct; 13(5):261-8. PubMed ID: 3021619
[TBL] [Abstract][Full Text] [Related]
34. The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+, CD8- T cells and is restricted to the DR region of the MHC complex.
Schmid DS
J Immunol; 1988 May; 140(10):3610-6. PubMed ID: 2834445
[TBL] [Abstract][Full Text] [Related]
35. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
Cunningham AL; Noble JR
J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
[TBL] [Abstract][Full Text] [Related]
36. Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity.
Bishop GA; Glorioso JC; Schwartz SA
J Exp Med; 1983 May; 157(5):1544-61. PubMed ID: 6189940
[TBL] [Abstract][Full Text] [Related]
37. Role of interferon in human natural killer activity against target cells infected with HSV-1.
Bishop GA; Glorioso JC; Schwartz SA
J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity amongst natural killer cells revealed by limiting dilution culture; selectivity against virus-infected and tumour cell targets.
Mason PD; Sissons JG; Borysiewicz LK
Immunology; 1993 Dec; 80(4):625-32. PubMed ID: 8307613
[TBL] [Abstract][Full Text] [Related]
39. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis.
Cunningham AL; Nelson PA; Fathman CG; Merigan TC
J Gen Virol; 1985 Feb; 66 ( Pt 2)():249-58. PubMed ID: 2981967
[TBL] [Abstract][Full Text] [Related]
40. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
Tamesis RR; Foster CS
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
